Treating disorders by application of insulin-like growth factors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 2, 530347, 530374, A61K 3724, A61K 3800, G07K 710

Patent

active

057030456

ABSTRACT:
A method of enhancing the survival of neuronal cells in a mammal, the cells being at risk of dying, the method comprising administering to the mammal an effective amount of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; a functional derivative of IGF-II; IGF-III; or a functional derivative of IGF-III.

REFERENCES:
patent: 4511390 (1985-04-01), Kauer
patent: 4699875 (1987-10-01), Appel
patent: 4783524 (1988-11-01), Larsen et al.
patent: 4801575 (1989-01-01), Pardridge
patent: 5068224 (1991-11-01), Fryklund et al.
Webster's New Ninth Collegiate Dictionary, ed. F.C. Mishi et al., Merriam-Webster, Inc., p. 413 (1990).
Nilsson et al., Neurosci: Lett, 88:222-26 (1988).
Sjogerg et al., Brain Res. 485:102-108 (1989).
Krusel et al., J. Neurosci., 10:558-70 (1990).
Hartikka and Hefti, J. Neurosci., 8(8):2967-85 (1988).
Kastin et al., Pharmacol., Biochem. & Behavior, 11:713-716(1979).
Baxter, Comp. Biochem. Physiol. 91B:229-235, 1988.
Daughaday et al., Endocrine Rev. 10:68-91, 1989.
D'Ercole, J. Devel. Physiol. 9:481-495, 1987.
Hintz et al., Horm. Metab. Res. 20:344-347, 1988.
Baskin et al., TINS 11:107-111, 1988.
Sara et al., Proc. Natl. Acad. Sci. USA 83:4904-4907, 1986.
Francis et al., Biochem. J. 251:95-103, 1988.
Sara et al., Neurosci. Let. 34:39-44, 1982.
Aizenman et al., Brain Res. 406:32-42, 1987.
Fellows et al., Soc. Neurosci. 13:1615, Abstract 445.14, 1987.
Onifer et al., Soc. Neurosci. 13:1615, Abstract 445.13, 1987.
Bothwell, J. Neurosci. Res. 8:225-231, 1982.
Recio-Pinto et al., J. Neurosci. 6:1211-1219, 1986.
Recio-Pinto et al., J. Neurosci. Res. 19:312-320, 1988.
Mattsson et al., J. Cell Biol. 102:1949-54, 1986.
Sara et al., J. Dev. Physiol. 1:343-350, 1979.
Sara et al., Prog. Brain Res. 73:87-99, 1988.
Sara et al., Neurobiol. Aging 3:117-120, 1982.
Nilsson et al., Neurosci. Let. 88:221-226, 1988.
Hansson et al., Acta. Physiol. Scand. 132:35-41, 1988.
Sjoberg et al., Brain Res. 485:102-108, 1989.
Coy et al., Biochem. Biophys. Res. Commun. 73:632-8, 1976.
Pardridge, Endocrine Reviews 7:314-330, 1986.
Blundell et al., Fed. Proc. 42:2592-2597, 1983.
Kastin et al., Pharmac. Biochem. Behav. 11:713-716, 1979.
Rapoport et al.,Science 207:84-86, 1980.
Pardridge et al., Biochem. Biophys. Res. Commun. 146:307-313, 1987.
Riekkinen et al., Peptides 8:261-265, 1987.
Creveling et al., Experienta 25:26-27, 1969.
Bodor et al., Science 214:1370-1372, 1981.
Francis et al., Art to Science in Tissue Culture, HyClone Laboratories, Inc., vol. 11, pp. 3, 5, 6, and 7, Winter 1992.
McManaman et al., Dev. Biol. 112:248-252, 1985.
Schwartz et al., Dev. Brain Res. 1:403-413, 1981.
Kanje et al., Brain Res. 381:24-28, 1986.
Hansson et al., Acta. Physiol. Scand. 126:609-614, 1986.
Sara et al., Biol. Psychiat. 18:803-811, 1983.
MacDonnell et al., Proc. Natl. Acad. Sci. USA 74:4681-4684, 1977.
Schwartz et al., Archives of Biochemistry & Biophysics 181:542-549, 1977.
Hintz et al., J. Clinical Endocrinology and Metabolism 54:442-446, 1982.
Russell et al., Life Sciences 19:1297-1306, 1976.
Rinehart et al., Proc. Natl. Acad. Sci. USA 82:4365-4368, 1985.
Hartikka et al., The Journal of Neuroscience 8:2967-2985, 1988.
Hayashi et al., Developmental Brain Research 36:109-120, 1987.
Knusel et al., The Journal of Neuroscience 10:558-570, 1990.
Recio-Pinto et al., Proc. Natl. Acad. Sci. 81:2562-2566, 1984.
Williams et al., Proc. Natl. Acad. Sci. 83:9231-9235, 1986.
Taylor et al., Drug Development Research 11:75-86, 1987.
DiCicco-Bloom et al., Proc. Natl. Acad. Sci. 85:4066-4070, 1988.
McManaman et al., Neuron 4:891-898, 1990.
Oppenheim et al., Science 251:1616-1617, 1991.
Hayward et al. in Peptides 1974-Proceedings of the Thirteenth European Peptide Symposium. Wolman, Editor. John Wiley & Sons (New York), 1974, pp. 287-295.
Goodman et al., Accounts of Chemical Research 12:1-7, 1979.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treating disorders by application of insulin-like growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating disorders by application of insulin-like growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating disorders by application of insulin-like growth factors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-202254

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.